West Pharmaceutical Services | WST - Debt

Stock Price
302.89
Daily Change
2.70 0.90%
Monthly
12.26%
Yearly
39.81%
Q2 Forecast
296.80

West Pharmaceutical Services reported $202.8M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Align Technology USD 114.45M 6.82M Dec/2025
Avanos Medical USD 129.1M 4.6M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Cerus USD 84.16M 791K Dec/2024
Charles River Laboratories USD 2.57B 58.23M Dec/2025
Cooper Companies USD 2.51B 27M Sep/2025
Dentsply International USD 2.33B 137M Mar/2026
Haemonetics USD 1.22B 5K Dec/2025
ICU Medical USD 1.28B 79.88M Dec/2025
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
IQVIA Holdings USD 15.83B 109M Mar/2026
J&J USD 47.93B 2.14B Dec/2025
Medtronic USD 28.07B 1.03B Dec/2025
Merit Medical Systems USD 821.57M 420K Dec/2025
Neogen USD 792.93M 396K Sep/2025
OraSure Technologies USD 782K 465K Jun/2024
Quidel USD 2.83B 9.9M Dec/2025
Repligen USD 546.58M 4.37M Mar/2026
Solventum Corp USD 7.91B 97M Mar/2025
STAAR Surgical USD 38.35M 764K Dec/2025
Terumo JPY 159.87B 14.97B Sep/2025
Utah Medical Products USD 0 0 Mar/2022
West Pharmaceutical Services USD 202.8M 0 Mar/2026